NURECA Share Price hits 10% UPPER CIRCUIT: Know the reason WHY
Nureca share price closed yesterday at Rs 1105.5, up Rs 110 or 10%. The products of Nureca will be in good demand considering the Covid fears are resurfacing in India. Last year it was Oximeter and Thermometer while going forward it can be any other product or technology. Due to increasing Covid cases, Nureca will see good demand for their products and that’s the key reason that the stock price is locked at the upper circuit
Nureca share price closed yesterday at Rs 1105.5, up Rs 110 or 10%. The products of Nureca will be in good demand considering the Covid fears are resurfacing in India. Last year it was Oximeter and Thermometer while going forward it can be any other product or technology. Due to increasing Covid cases, Nureca will see good demand for their products and that’s the key reason that the stock price is locked at the upper circuit.
This newly listed IPO multiplied investor’s money 2.75x in almost 45 days after getting listed. The IPO was issued at Rs 400 to investors. The share price of Nureca closed at a day's high. Many analysts on the street are extremely bullish on Nureca after the strong Management commentary and vision they have for the business. Brokerages report will kick in after meeting the management of Nureca in a few days highlighting the business prospects and the upgrades. With Covid fears resurfacing, it is expected that the company products are going to see increased demand. This company is into the medical equipment business and the market cap of Nureca is Rs 1105 cr. Many Analysts believe that the model of the business is strong enough to generate good growth in future.
See Zee Business Live TV Streaming Below:
Zee Business Managing Editor Anil Singhvi spoke to Founder and CEO of the Nureca Aryan Goyal on his show where he had said that they have a contract manufacturing model of business. So, it may happen that suppliers may think of selling their products on their own. In that case, Nureca is also planning to foray into the manufacturing zone where they have a small manufacturing unit though it's very small. He said that Nureca has been introducing new products and technology that have been keeping its business volume at the same levels.
Nureca is a B2C company engaged in the business of home healthcare and wellness products which offers quality, durability, functionality, usability and innovative designs. Post COVID-19 the health awareness is surmounting and devices like Pulse Oximeters, Thermometers, Nebulizers, Self-monitoring glucose Devices, Humidifier and Steamers, wheelchairs, walkers, lumbar, breast pumps, bottle sterilizers, bottle warmers, car seats, baby carrycots, Nutrition supplements, Lifestyle products etc. are catching attention.
NURECA is marketing its products in India on its own website drtrust.in and also using third-party e-commerce platforms, distributors and retailers. According to management, since the onset of the COVID-19 pandemic in March 2020, the company has responded swiftly by implementing various processes to ensure continuous and seamless operations that have resulted in the boosted top and bottom lines. NURECA is selling its products under the brand names of "Dr.Trust", "Dr. Physio" and "TRUMOM".
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Latest FD Interest Rates: What SBI, PNB, HDFC Bank, ICICI Bank and other banks are offering in 3-year fixed deposit schemes
SBI Senior Citizen FD Interest Rates: Know how Rs 5 lakh, Rs 10 lakh, and Rs 15 lakh investments will give in maturity in Amrit Vrishti, 1-, 3-, and 5-year fixed deposit schemes
Top 7 ETFs That Have Given up to 59% Returns in 1 Year: No. 1 ETF has turned Rs 3 lakh investment into Rs 4.65 lakh; know about others too
10:28 AM IST